Home » Stocks » SRI

Stoneridge, Inc. (SRI)

Stock Price: $30.66 USD -1.23 (-3.86%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
Market Cap 827.98M
Revenue (ttm) 648.01M
Net Income (ttm) -7.95M
Shares Out 27.03M
EPS (ttm) -0.29
PE Ratio n/a
Forward PE 32.57
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $30.66
Previous Close $31.89
Change ($) -1.23
Change (%) -3.86%
Day's Open 31.31
Day's Range 30.22 - 31.85
Day's Volume 297,355
52-Week Range 13.87 - 33.39

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 3 months ago

NOVI, Mich., Nov. 11, 2020 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) today announced that Jon DeGaynor, president and chief executive officer, and Bob Krakowiak, chief financial officer, wi...

Seeking Alpha - 4 months ago

Stoneridge' (SRI) CEO Jon DeGaynor on Q3 2020 Results - Earnings Call Transcript

PRNewsWire - 4 months ago

NOVI, Mich., Oct. 30, 2020 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) today announced that Jon DeGaynor, president and chief executive officer, and Bob Krakowiak, chief financial officer, wi...

Zacks Investment Research - 4 months ago

Stoneridge (SRI) delivered earnings and revenue surprises of 200.00% and 15.14%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 4 months ago

Stoneridge (SRI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRNewsWire - 5 months ago

NOVI, Mich., Sept. 22, 2020 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) today announced it received the award for 2020 U.S. Best Overall Investor Relations (Small Cap) from IR Magazine. The a...

PRNewsWire - 5 months ago

NOVI, Mich., Sept. 2, 2020 /PRNewswire/ -- Stoneridge, Inc.

PRNewsWire - 6 months ago

NOVI, Mich., Aug. 28, 2020 /PRNewswire/ -- Recognized for his leadership and entrepreneurial vision, Jon DeGaynor of Stoneridge, Inc.

Zacks Investment Research - 6 months ago

If you own a toxic stock for long, you are likely to see a big loss in your wealth. Discarding them at the right time is the key to shield your portfolio from big losses.

Other stocks mentioned: CWK, ILMN, PRLB
PRNewsWire - 6 months ago

NOVI, Mich., Aug. 3, 2020 /PRNewswire/ -- Stoneridge, Inc.

Seeking Alpha - 6 months ago

Stoneridge, Inc. (SRI) CEO Jonathan DeGaynor on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 7 months ago

Investors who can figure out the overpriced toxic stocks and shun them at the right time are the ones that are likely to benefit.

Other stocks mentioned: ALRM, EPAY, HQY, MERC
PRNewsWire - 7 months ago

NOVI, Mich., July 16, 2020 /PRNewswire/ -- Stoneridge, Inc.

Zacks Investment Research - 7 months ago

Figuring out toxic stocks and abandoning them at the right time is the key to shield your portfolio from big losses.

Other stocks mentioned: CWK, EPAY, NFE, TSE
PRNewsWire - 8 months ago

NOVI, Mich., June 3, 2020 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) today announced that Jon DeGaynor, chief executive officer, and Bob Krakowiak, chief financial officer, will participate ...

PRNewsWire - 9 months ago

NOVI, Mich., May 27, 2020 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) today announced that Jon DeGaynor, president and chief executive officer, and Bob Krakowiak, chief financial officer, wil...

Seeking Alpha - 9 months ago

Stoneridge, Inc. (SRI) CEO Jon DeGaynor on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

Stoneridge (SRI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 1 year ago

Stoneridge, Inc. (SRI) CEO Jon DeGaynor on Q4 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Stoneridge, Inc. (SRI) CEO Jon DeGaynor on Q3 2019 - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Stoneridge (SRI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

SRI vs. NJDCY: Which Stock Is the Better Value Option?

Zacks Investment Research - 1 year ago

SRI vs. OLED: Which Stock Is the Better Value Option?

Other stocks mentioned: OLED
Zacks Investment Research - 1 year ago

Is Stoneridge (SRI) a great pick from the value investor's perspective right now? Read on to know more.

Seeking Alpha - 1 year ago

Stoneridge, Inc. (SRI) CEO Jon DeGaynor on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Stoneridge (SRI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 1 year ago

Stoneridge, Inc. (SRI) CEO Jon DeGaynor on Q1 2019 Results - Earnings Call Transcript

Zacks Investment Research - 2 years ago

Stoneridge (SRI) and Kimco Realty (KIM): Today's Bull & Bear

Learn more about the Bull and Bear of the day

Other stocks mentioned: KIM

About SRI

Stoneridge, together with its subsidiaries, designs and manufactures engineered electrical and electronic components, modules, and systems for the automotive, commercial, off-highway, motorcycle, and agricultural vehicle markets. The company operates in three segments: Control Devices, Electronics, and Stoneridge Brazil. The Control Devices segment offers sensors, switches, and actuators that monitor, measure, or activate specific functions within a vehicle. The Electronics segment designs and manufactures driver information systems, camera-bas... [Read more...]

Industry
Auto Parts
IPO Date
Oct 10, 1997
CEO
Jonathan DeGaynor
Employees
4,700
Stock Exchange
NYSE
Ticker Symbol
SRI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Stoneridge stock is "Buy." The 12-month stock price forecast is 32.50, which is an increase of 6.00% from the latest price.

Price Target
$32.50
(6.00% upside)
Analyst Consensus: Buy